Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Intellia Therapeutics (NTLA) Other Gross PP&E Adjustments (2016 - 2026)

Intellia Therapeutics has reported Other Gross PP&E Adjustments over the past 12 years, most recently at -$106.2 million for Q1 2026.

  • Quarterly Other Gross PP&E Adjustments rose 24.74% to -$106.2 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was -$106.2 million through Mar 2026, up 24.74% year-over-year, with the annual reading at -$31.9 million for FY2025, 81.97% up from the prior year.
  • Other Gross PP&E Adjustments was -$106.2 million for Q1 2026 at Intellia Therapeutics, down from -$31.9 million in the prior quarter.
  • Over five years, Other Gross PP&E Adjustments peaked at -$31.9 million in Q4 2025 and troughed at -$177.0 million in Q4 2024.
  • The 5-year median for Other Gross PP&E Adjustments is -$109.0 million (2024), against an average of -$108.3 million.
  • Year-over-year, Other Gross PP&E Adjustments crashed 1960.19% in 2022 and then soared 81.97% in 2025.
  • A 5-year view of Other Gross PP&E Adjustments shows it stood at -$94.5 million in 2022, then grew by 22.55% to -$73.2 million in 2023, then crashed by 141.99% to -$177.0 million in 2024, then soared by 81.97% to -$31.9 million in 2025, then plummeted by 232.85% to -$106.2 million in 2026.
  • Per Business Quant, the three most recent readings for NTLA's Other Gross PP&E Adjustments are -$106.2 million (Q1 2026), -$31.9 million (Q4 2025), and -$120.6 million (Q3 2025).